Visiopharm

We are a leading provider of AI-driven precision pathology software.

[Visiopharm @Visiopharm]

We are moving to Bluesky! Follow us to stay updated on our latest news :)

https://t.co/zvPzBVY6D6

[Visiopharm @Visiopharm]

✨ Season's Greetings from all of us at Visiopharm!
Thank you to our customers, employees, and partners for a fantastic 2024. We’re excited to achieve even more together in 2025!

[Visiopharm @Visiopharm]

Lucy Hillary from CRUK Scotland Institute presenting her study at ESSB in Berlin. Her poster highlights the use of Visiopharm for tissue classification and fibroblast detection using Visiopharm's Deep Learning tools. Check out poster #77 today!

[Visiopharm @Visiopharm]

Good morning from Berlin! We're thrilled to be at the European Society for Spatial Biology (ESSB) and look forward to connecting with you to discuss all things spatial biology. 👋 Swing by booth #26 and discover how Phenoplex software is transforming spatial biology analysis

[Visiopharm @Visiopharm]

Dr. Marilyn Bui is live at DPC in London presenting Qualitopix, our tool for measuring and documenting your staining consistency through standardized analysis of next generation reference materials. If you missed her talk, learn more about Qualitopix here:https://t.co/QABaakzFeA

[Visiopharm @Visiopharm]

Day 2 at the Digital Pathology & AI Congress is in full swing, and our team of AI experts is here to connect with you! Stop by booth #24 to meet Rickard Lindelöf, Sunita Kumar, and Matthew Burke PhD, and discover how we can help you stay ahead in digital pathology.

[Visiopharm @Visiopharm]

Our team is ready to meet you at the Digital Pathology & AI congress in London! Come by booth #24 and explore our innovative solutions for tissue research and diagnostics 👏

[Visiopharm @Visiopharm]

Attending SABCS today in San Antonio? Jeppe Thagaard is presenting our AI-driven innovation for HER2 scoring including HER-low and –ultralow. Visit our poster from 5:30-7:00PM - Harnessing Technology: A comparative study of AI versus manual scoring in HER2 Ultra-low breast cancer

[King's Innovation Catalyst @Kings_Catalyst]

👩‍🔬 Calling all cancer researchers and innovators at @KingsCollegeLon!

Find out how @Visiopharm's Phenoplex software is already being used by research scientists and postdocs at King's, and discover new partnering opportunities.

👉 Join on 21 January: https://t.co/LtE50gDWYd

[Visiopharm @Visiopharm]

Join us at #SABCS24! Jeppe Thagaard, Visiopharm Scientific Director, will present with The Christie NHS Trust: "Harnessing Technology: AI vs. manual scoring in HER2 Ultra-low breast cancer." on Dec 11, 5:30 – 7:00 PM (Poster session 2).

[Visiopharm @Visiopharm]

Are you attending the European Society for Spatial Biology in Berlin? We’ll be at booth #26, presenting our latest developments in spatial biology! See you next week!
@SpatialBio

[Visiopharm @Visiopharm]

Last week, we had the pleasure of joining Lunaphore's Spatial Biology Tour in Copenhagen! Niklas Petersen took the stage to showcase #Phenoplex, our complete workflow-based approach to analyzing high-plex imagery. @lunaphore

[Visiopharm @Visiopharm]

Discover how AI-powered automation in spatial profiling helps explore hypoxia's impact on head and neck cancer. Visiopharm's Oncotopix + GeoMx DSP enables high-throughput and unbiased insights into TME! @brukerspatial https://t.co/amwhGN0dSi

[Visiopharm @Visiopharm]

Are you attending the European Society for Spatial Biology in Berlin? We’ll be there at booth #26 presenting our recent developments in spatial biology!

[Visiopharm @Visiopharm]

Joining the Digital Pathology & AI conference in London? We’re thrilled to showcase Visiopharm’s advanced AI-powered software solutions — backed by 20+ years of collaboration with pathologists and research scientists worldwide. Stop by booth #24!

[Visiopharm @Visiopharm]

We are excited to become a preferred partner to PathAI with the integration of our precision pathology APPs into the AISight Image Management System (IMS). Read the press release: https://t.co/FFC4NUQUUv

[Visiopharm @Visiopharm]

Masterclass tomorrow! Join us to see a novel phenotyping method developed by Rachel Pennie (CRUK Scotland Institute) using our Phenoplex software! Sign-up now: https://t.co/yuiFFIjMXS

[Visiopharm @Visiopharm]

Join us in this workshop, hosted by Mass General Research Institute (MHGRI), to learn more about Phenoplex, Visiopharm's complete workflow for multiplex spatial biology image analysis. Registration: https://t.co/1emvo2Ojkz

[Visiopharm @Visiopharm]

Join us for the final masterclass of 2024, featuring Rachel Pennie, Scientific Officer at Cancer Research UK (CRUK) Scotland Institute! Register here: https://t.co/U2Jq3NcsgO

[Visiopharm @Visiopharm]

Joshua Nordberg from RareCyte presenting our joint poster at #SITC: Phenoplex™ spatial analysis of whole-slide colon adenocarcinoma imaged with Orion™ 13-plex one-round staining and imaging.
https://t.co/9HxKblJo5e